Suchergebnisse - "Podzamczer, Daniel"

PubPharm (138)

1

Switching to bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) plus darunavir/cobicistat in heavily antiretroviral-experienced, virologically suppressed HIV-infected adults receiving complex regimens

enthalten in: The Journal of antimicrobial chemotherapy | 2023

von Podzamczer, D. | Imaz, A. | Lopez-Lirola, A. | +25

2

Decay of HIV RNA in Seminal Plasma and Rectal Fluid in Treatment-Naive Adults Starting Antiretroviral Therapy With Dolutegravir Plus Lamivudine or Bictegravir/Emtricitabine/Tenofovir Alafenamide

enthalten in: The Journal of infectious diseases | 2023

von Scévola, S. | Niubó, J. | Domingo, P. | +10

3

Long-term effects on subclinical cardiovascular disease of switching from boosted protease inhibitors to dolutegravir

enthalten in: The Journal of antimicrobial chemotherapy | 2023

von González-Cordón, A. | Assoumou, L. | Moyle, G. | +117

4

Assessing the Virologic Impact of Archived Resistance in the Dolutegravir/Lamivudine 2-Drug Regimen HIV-1 Switch Study TANGO through Week 144

enthalten in: Viruses | 2023

von Wang, R. | Wright, J. | Saggu, P. | +11

5

Detecting anal human papillomavirus infection in men who have sex with men living with HIV : implications of assay variability

enthalten in: Sexually transmitted infections | 2023

von Torres, M. | Silva-Klug, A. | Ferrer, E. | +10

6

Limited Weight Impact After Switching From Boosted Protease Inhibitors to Dolutegravir in Persons With Human Immunodeficiency Virus With High Cardiovascular Risk : A Post Hoc Analysis of the 96-Week NEAT-022 Randomized Trial

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2023

von Waters, L. | Assoumou, L. | González-Cordón, A. | +121

7

Effectiveness and safety of integrase strand transfer inhibitors in Spain : a prospective real-world study

enthalten in: Frontiers in cellular and infection microbiology | 2023

von Santos, J. | Casadellà, M. | Noguera-Julian, M. | +59

8

Doravirine Concentrations and Human Immunodeficiency Virus Type 1 RNA in the Genital Fluids of Virologically Suppressed Adults Switching to Doravirine Plus Emtricitabine/Tenofovir Alafenamide

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2022

von Scévola, S. | Imaz, A. | Cottrell, M. | +8

9

Long-lasting adaptive immune memory specific to SARS-CoV-2 in convalescent coronavirus disease 2019 stable people with HIV

enthalten in: AIDS (London, England) | 2022

von Donadeu, L. | Tiraboschi, J. | Scévola, S. | +13

10

Atherogenicity of low-density lipoproteins after switching from a protease inhibitor to dolutegravir : a substudy of the NEAT022 study

enthalten in: The Journal of antimicrobial chemotherapy | 2022

von Saumoy, M. | Sánchez-Quesada, J. | Assoumou, L. | +12

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[14]